Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
8,908
archived clinical trials in
Renal Impairment / Chronic Kidney Disease

4 Week Switch Study in Hemodialysis-dependent Subjects With Anemia Associated With Chronic Kidney Disease
A Four-week, Phase IIa, Randomized, Active-controlled, Parallel-group, Multi-center Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Switching Subjects From a Stable Dose of Recombinant Human Erythropoietin to GSK1278863 in Hemodialysis-dependent Subjects With Anemia Associated With Chronic Kidney Disease
Status: Enrolling
Updated:  10/12/2017
GSK Investigational Site
mi
from
Calgary,
4 Week Switch Study in Hemodialysis-dependent Subjects With Anemia Associated With Chronic Kidney Disease
A Four-week, Phase IIa, Randomized, Active-controlled, Parallel-group, Multi-center Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Switching Subjects From a Stable Dose of Recombinant Human Erythropoietin to GSK1278863 in Hemodialysis-dependent Subjects With Anemia Associated With Chronic Kidney Disease
Status: Enrolling
Updated: 10/12/2017
GSK Investigational Site
mi
from
Calgary,
Click here to add this to my saved trials
An Intensive Lifestyle Intervention Program in CKD (Move to Health 2)
An Intensive Lifestyle Intervention Program in CKD (Move to Health 2)
Status: Enrolling
Updated:  10/12/2017
Springfield College
mi
from
Springfield, MA
An Intensive Lifestyle Intervention Program in CKD (Move to Health 2)
An Intensive Lifestyle Intervention Program in CKD (Move to Health 2)
Status: Enrolling
Updated: 10/12/2017
Springfield College
mi
from
Springfield, MA
Click here to add this to my saved trials
Differential Effects of Ergocalciferol and Cholecalciferol Therapies in Chronic Kidney Disease
Differential Effects of Ergocalciferol and Cholecalciferol Therapies in Chronic Kidney Disease
Status: Enrolling
Updated:  10/17/2017
University of Kansas Medical Center
mi
from
Kansas City, KA
Differential Effects of Ergocalciferol and Cholecalciferol Therapies in Chronic Kidney Disease
Differential Effects of Ergocalciferol and Cholecalciferol Therapies in Chronic Kidney Disease
Status: Enrolling
Updated: 10/17/2017
University of Kansas Medical Center
mi
from
Kansas City, KA
Click here to add this to my saved trials
Autosomal Dominant Polycystic Kidney Disease (ADPKD) Pain Study
Evaluation and Treatment of Chronic Pain in Autosomal Dominant Polycystic Kidney Disease
Status: Enrolling
Updated:  10/18/2017
The Mayo Clinic
mi
from
Rochester, MN
Autosomal Dominant Polycystic Kidney Disease (ADPKD) Pain Study
Evaluation and Treatment of Chronic Pain in Autosomal Dominant Polycystic Kidney Disease
Status: Enrolling
Updated: 10/18/2017
The Mayo Clinic
mi
from
Rochester, MN
Click here to add this to my saved trials
Short-term Atorvastatin's Effect on Acute Kidney Injury Following Cardiac Surgery
Short-term Atorvastatin's Effect on Acute Kidney Injury Following Cardiac Surgery
Status: Enrolling
Updated:  10/18/2017
Vanderbilt University Medical Center
mi
from
Nashville, TN
Short-term Atorvastatin's Effect on Acute Kidney Injury Following Cardiac Surgery
Short-term Atorvastatin's Effect on Acute Kidney Injury Following Cardiac Surgery
Status: Enrolling
Updated: 10/18/2017
Vanderbilt University Medical Center
mi
from
Nashville, TN
Click here to add this to my saved trials
Pasireotide LAR in Severe Polycystic Liver Disease
A Randomized, Placebo Controlled Clinical Trial of SOM230 (Pasireotide LAR) In Severe Polycystic Liver Disease
Status: Enrolling
Updated:  10/18/2017
The Mayo Clinic
mi
from
Rochester, MN
Pasireotide LAR in Severe Polycystic Liver Disease
A Randomized, Placebo Controlled Clinical Trial of SOM230 (Pasireotide LAR) In Severe Polycystic Liver Disease
Status: Enrolling
Updated: 10/18/2017
The Mayo Clinic
mi
from
Rochester, MN
Click here to add this to my saved trials
Prospective Observational Study of Erythropoietin-Iron Interaction in Anemia of Renal Disease
Computational Approach to Personalized Anemia Management
Status: Enrolling
Updated:  10/24/2017
University of Louisville, University Kidney Center
mi
from
Louisville, KY
Prospective Observational Study of Erythropoietin-Iron Interaction in Anemia of Renal Disease
Computational Approach to Personalized Anemia Management
Status: Enrolling
Updated: 10/24/2017
University of Louisville, University Kidney Center
mi
from
Louisville, KY
Click here to add this to my saved trials
Prospective Observational Study of Erythropoietin-Iron Interaction in Anemia of Renal Disease
Computational Approach to Personalized Anemia Management
Status: Enrolling
Updated:  10/24/2017
Western New England Renal & Transplant Associates, PC
mi
from
Springfield, MA
Prospective Observational Study of Erythropoietin-Iron Interaction in Anemia of Renal Disease
Computational Approach to Personalized Anemia Management
Status: Enrolling
Updated: 10/24/2017
Western New England Renal & Transplant Associates, PC
mi
from
Springfield, MA
Click here to add this to my saved trials
Prospective Observational Study of Erythropoietin-Iron Interaction in Anemia of Renal Disease
Computational Approach to Personalized Anemia Management
Status: Enrolling
Updated:  10/24/2017
Duke University
mi
from
Durham, NC
Prospective Observational Study of Erythropoietin-Iron Interaction in Anemia of Renal Disease
Computational Approach to Personalized Anemia Management
Status: Enrolling
Updated: 10/24/2017
Duke University
mi
from
Durham, NC
Click here to add this to my saved trials
A Trial of Sertraline vs. CBT for End-stage Renal Disease Patients With Depression {ASCEND}
ASCEND: A Trial of Sertraline vs. CBT for End-stage Renal Disease Patients With Depression
Status: Enrolling
Updated:  10/24/2017
University of New Mexico
mi
from
Albuquerque, NM
A Trial of Sertraline vs. CBT for End-stage Renal Disease Patients With Depression {ASCEND}
ASCEND: A Trial of Sertraline vs. CBT for End-stage Renal Disease Patients With Depression
Status: Enrolling
Updated: 10/24/2017
University of New Mexico
mi
from
Albuquerque, NM
Click here to add this to my saved trials
A Trial of Sertraline vs. CBT for End-stage Renal Disease Patients With Depression {ASCEND}
ASCEND: A Trial of Sertraline vs. CBT for End-stage Renal Disease Patients With Depression
Status: Enrolling
Updated:  10/24/2017
University of Texas Southwestern
mi
from
Dallas, TX
A Trial of Sertraline vs. CBT for End-stage Renal Disease Patients With Depression {ASCEND}
ASCEND: A Trial of Sertraline vs. CBT for End-stage Renal Disease Patients With Depression
Status: Enrolling
Updated: 10/24/2017
University of Texas Southwestern
mi
from
Dallas, TX
Click here to add this to my saved trials
A Trial of Sertraline vs. CBT for End-stage Renal Disease Patients With Depression {ASCEND}
ASCEND: A Trial of Sertraline vs. CBT for End-stage Renal Disease Patients With Depression
Status: Enrolling
Updated:  10/24/2017
Univ of Washington
mi
from
Seattle, WA
A Trial of Sertraline vs. CBT for End-stage Renal Disease Patients With Depression {ASCEND}
ASCEND: A Trial of Sertraline vs. CBT for End-stage Renal Disease Patients With Depression
Status: Enrolling
Updated: 10/24/2017
Univ of Washington
mi
from
Seattle, WA
Click here to add this to my saved trials
Use of Pedometers to Measure and Increase Walking Among Patients With ESRD
Use of Pedometers to Measure and Increase Walking Among Patients With ESRD
Status: Enrolling
Updated:  10/24/2017
University of California at San Francisco
mi
from
San Francisco, CA
Use of Pedometers to Measure and Increase Walking Among Patients With ESRD
Use of Pedometers to Measure and Increase Walking Among Patients With ESRD
Status: Enrolling
Updated: 10/24/2017
University of California at San Francisco
mi
from
San Francisco, CA
Click here to add this to my saved trials
Does a Mainstream Summer Camp Experience Improve Pediatric Kidney Patients' Physical Fitness and Self Concept?
Does a Mainstream Summer Camp Experience Improve Pediatric Kidney Patients' Physical Fitness and Self Concept?
Status: Enrolling
Updated:  10/24/2017
Frost Valley YMCA
mi
from
Claryville, NY
Does a Mainstream Summer Camp Experience Improve Pediatric Kidney Patients' Physical Fitness and Self Concept?
Does a Mainstream Summer Camp Experience Improve Pediatric Kidney Patients' Physical Fitness and Self Concept?
Status: Enrolling
Updated: 10/24/2017
Frost Valley YMCA
mi
from
Claryville, NY
Click here to add this to my saved trials
Health Outcomes Patient Education
Health Outcomes Patient Education
Status: Enrolling
Updated:  10/26/2017
San Francisco VA Medical Center: Clinical Research Center
mi
from
San Francisco, CA
Health Outcomes Patient Education
Health Outcomes Patient Education
Status: Enrolling
Updated: 10/26/2017
San Francisco VA Medical Center: Clinical Research Center
mi
from
San Francisco, CA
Click here to add this to my saved trials
Efficacy of Statins In Prevention of CIN
Efficacy Of Statins In The Prevention of Contrast-Induced Nephropathy in Patients With Chronic Renal Insufficiency (SCIN Trial): A Double-Blind, Placebo-Controlled Trial
Status: Enrolling
Updated:  10/27/2017
Oklahoma University Health Science Center
mi
from
Oklahoma City, OK
Efficacy of Statins In Prevention of CIN
Efficacy Of Statins In The Prevention of Contrast-Induced Nephropathy in Patients With Chronic Renal Insufficiency (SCIN Trial): A Double-Blind, Placebo-Controlled Trial
Status: Enrolling
Updated: 10/27/2017
Oklahoma University Health Science Center
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Efficacy of Statins In Prevention of CIN
Efficacy Of Statins In The Prevention of Contrast-Induced Nephropathy in Patients With Chronic Renal Insufficiency (SCIN Trial): A Double-Blind, Placebo-Controlled Trial
Status: Enrolling
Updated:  10/27/2017
Veterans Affairs Medical Center
mi
from
Oklahoma City, OK
Efficacy of Statins In Prevention of CIN
Efficacy Of Statins In The Prevention of Contrast-Induced Nephropathy in Patients With Chronic Renal Insufficiency (SCIN Trial): A Double-Blind, Placebo-Controlled Trial
Status: Enrolling
Updated: 10/27/2017
Veterans Affairs Medical Center
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Improving Blood Pressure Control in End-Stage Renal Disease Through a Supportive-Educative Nursing Intervention
Improving Blood Pressure Control in End-Stage Renal Disease Through a Supportive-Educative Nursing Intervention
Status: Enrolling
Updated:  11/1/2017
Davita Detroit Kresge Hemodialysis Unit
mi
from
Detroit, MI
Improving Blood Pressure Control in End-Stage Renal Disease Through a Supportive-Educative Nursing Intervention
Improving Blood Pressure Control in End-Stage Renal Disease Through a Supportive-Educative Nursing Intervention
Status: Enrolling
Updated: 11/1/2017
Davita Detroit Kresge Hemodialysis Unit
mi
from
Detroit, MI
Click here to add this to my saved trials
Improving Blood Pressure Control in End-Stage Renal Disease Through a Supportive-Educative Nursing Intervention
Improving Blood Pressure Control in End-Stage Renal Disease Through a Supportive-Educative Nursing Intervention
Status: Enrolling
Updated:  11/1/2017
William Beaumont Hemodialysis Units
mi
from
Royal Oak, MI
Improving Blood Pressure Control in End-Stage Renal Disease Through a Supportive-Educative Nursing Intervention
Improving Blood Pressure Control in End-Stage Renal Disease Through a Supportive-Educative Nursing Intervention
Status: Enrolling
Updated: 11/1/2017
William Beaumont Hemodialysis Units
mi
from
Royal Oak, MI
Click here to add this to my saved trials
A Pharmacokinetic Study of AMG 386 in Cancer Subjects With Normal and Impaired Renal Function
An Open-label Pharmacokinetic Study of AMG 386 in Advanced Cancer Subjects With Normal and Impaired Renal Function
Status: Enrolling
Updated:  11/1/2017
Clinical Research Facility
mi
from
Atlanta, GA
A Pharmacokinetic Study of AMG 386 in Cancer Subjects With Normal and Impaired Renal Function
An Open-label Pharmacokinetic Study of AMG 386 in Advanced Cancer Subjects With Normal and Impaired Renal Function
Status: Enrolling
Updated: 11/1/2017
Clinical Research Facility
mi
from
Atlanta, GA
Click here to add this to my saved trials
A Pharmacokinetic Study of AMG 386 in Cancer Subjects With Normal and Impaired Renal Function
An Open-label Pharmacokinetic Study of AMG 386 in Advanced Cancer Subjects With Normal and Impaired Renal Function
Status: Enrolling
Updated:  11/1/2017
Clinical Research Facility
mi
from
Chicago, IL
A Pharmacokinetic Study of AMG 386 in Cancer Subjects With Normal and Impaired Renal Function
An Open-label Pharmacokinetic Study of AMG 386 in Advanced Cancer Subjects With Normal and Impaired Renal Function
Status: Enrolling
Updated: 11/1/2017
Clinical Research Facility
mi
from
Chicago, IL
Click here to add this to my saved trials
A Pharmacokinetic Study of AMG 386 in Cancer Subjects With Normal and Impaired Renal Function
An Open-label Pharmacokinetic Study of AMG 386 in Advanced Cancer Subjects With Normal and Impaired Renal Function
Status: Enrolling
Updated:  11/1/2017
Clinical Research Facility
mi
from
Lebanon, NH
A Pharmacokinetic Study of AMG 386 in Cancer Subjects With Normal and Impaired Renal Function
An Open-label Pharmacokinetic Study of AMG 386 in Advanced Cancer Subjects With Normal and Impaired Renal Function
Status: Enrolling
Updated: 11/1/2017
Clinical Research Facility
mi
from
Lebanon, NH
Click here to add this to my saved trials
A Pharmacokinetic Study of AMG 386 in Cancer Subjects With Normal and Impaired Renal Function
An Open-label Pharmacokinetic Study of AMG 386 in Advanced Cancer Subjects With Normal and Impaired Renal Function
Status: Enrolling
Updated:  11/1/2017
Clinical Research Facility
mi
from
Cleveland, OH
A Pharmacokinetic Study of AMG 386 in Cancer Subjects With Normal and Impaired Renal Function
An Open-label Pharmacokinetic Study of AMG 386 in Advanced Cancer Subjects With Normal and Impaired Renal Function
Status: Enrolling
Updated: 11/1/2017
Clinical Research Facility
mi
from
Cleveland, OH
Click here to add this to my saved trials
Pharmacokinetics of Sublingual Versus Oral Tacrolimus in Patients Awaiting Kidney Transplantation
Pharmacokinetic Evaluation of Sublingual Versus Oral Tacrolimus Administration in Patients Awaiting Kidney Transplantation
Status: Enrolling
Updated:  11/2/2017
NewYork-Presbyterian Hospital
mi
from
New York, NY
Pharmacokinetics of Sublingual Versus Oral Tacrolimus in Patients Awaiting Kidney Transplantation
Pharmacokinetic Evaluation of Sublingual Versus Oral Tacrolimus Administration in Patients Awaiting Kidney Transplantation
Status: Enrolling
Updated: 11/2/2017
NewYork-Presbyterian Hospital
mi
from
New York, NY
Click here to add this to my saved trials
ACTH Treatment of APOL1- Associated Nephropathy
ACTH Treatment of APOL1- Associated Nephropathy
Status: Enrolling
Updated:  11/3/2017
Wake Forest Baptist Medical Center
mi
from
Winston-Salem, NC
ACTH Treatment of APOL1- Associated Nephropathy
ACTH Treatment of APOL1- Associated Nephropathy
Status: Enrolling
Updated: 11/3/2017
Wake Forest Baptist Medical Center
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Pathways to Improving Functional Capacity in Older Patients With Chronic Kidney Disease and Cardiovascular Disease
Pathways to Improving Functional Capacity in Older Patients With Chronic Kidney Disease and Cardiovascular Disease
Status: Enrolling
Updated:  11/3/2017
Wake Forest Baptist Health Cardiac Rehab
mi
from
Winston-Salem, NC
Pathways to Improving Functional Capacity in Older Patients With Chronic Kidney Disease and Cardiovascular Disease
Pathways to Improving Functional Capacity in Older Patients With Chronic Kidney Disease and Cardiovascular Disease
Status: Enrolling
Updated: 11/3/2017
Wake Forest Baptist Health Cardiac Rehab
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Randomized Trial of 2 Antibody Induction Steroid Avoidance Protocols
Randomized Trial of 2 Antibody Induction Steroid Avoidance Protocols Accompanied by Maintenance Therapy With Prograf® and Myfortic®
Status: Enrolling
Updated:  11/5/2017
University of Miami Miller School of Medicine
mi
from
Miami, FL
Randomized Trial of 2 Antibody Induction Steroid Avoidance Protocols
Randomized Trial of 2 Antibody Induction Steroid Avoidance Protocols Accompanied by Maintenance Therapy With Prograf® and Myfortic®
Status: Enrolling
Updated: 11/5/2017
University of Miami Miller School of Medicine
mi
from
Miami, FL
Click here to add this to my saved trials
Presep and Vascath Interaction Study
A Pilot Study to Compare the Interaction Between Central Venous Mixed Venous Oxygen Saturation Catheters and Central Venous Hemodialysis Catheters
Status: Enrolling
Updated:  11/6/2017
Wake Forest University Health Sciences
mi
from
Winston-Salem, NC
Presep and Vascath Interaction Study
A Pilot Study to Compare the Interaction Between Central Venous Mixed Venous Oxygen Saturation Catheters and Central Venous Hemodialysis Catheters
Status: Enrolling
Updated: 11/6/2017
Wake Forest University Health Sciences
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Renal Transplant Injury and the Renin-Angiotensin System in Kids (RETASK)
Renal Transplant Injury and the Renin-Angiotensin System in Kids (RETASK)
Status: Enrolling
Updated:  11/6/2017
Wake Forest University Baptist Medical Center
mi
from
Winston-Salem, NC
Renal Transplant Injury and the Renin-Angiotensin System in Kids (RETASK)
Renal Transplant Injury and the Renin-Angiotensin System in Kids (RETASK)
Status: Enrolling
Updated: 11/6/2017
Wake Forest University Baptist Medical Center
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
FAST GFR: Pilot Study to Evaluate the Safety of the FAST GFR Test in Patients.
A Single-Center Prospective Study Evaluating the FAST Measured Glomerular Filtration Rate (mGFR) Test™ in Adults With Preserved Kidney Function and Impaired Kidney Function With Comparison to Iohexol Clearance Methods
Status: Enrolling
Updated:  11/13/2017
University of Alabama Birmingham, Division of Nephrology
mi
from
Birmingham, AL
FAST GFR: Pilot Study to Evaluate the Safety of the FAST GFR Test in Patients.
A Single-Center Prospective Study Evaluating the FAST Measured Glomerular Filtration Rate (mGFR) Test™ in Adults With Preserved Kidney Function and Impaired Kidney Function With Comparison to Iohexol Clearance Methods
Status: Enrolling
Updated: 11/13/2017
University of Alabama Birmingham, Division of Nephrology
mi
from
Birmingham, AL
Click here to add this to my saved trials
A Phase IV Trial of Repeated Doses of Ferumoxytol Compared to Iron Sucrose for the Treatment of Iron Deficiency Anemia in Patients With Chronic Kidney Disease on Hemodialysis
Ferumoxytol for Anemia of CKD Trial (FACT): A Phase IV, Open-Label, Multicenter Trial, With MRI Substudy, of Repeated Doses of Ferumoxytol Compared With Iron Sucrose for the Treatment of Iron Deficiency Anemia (IDA) in Chronic Kidney Disease (CKD) Patients on Hemodialysis
Status: Enrolling
Updated:  11/14/2017
AMAG Pharmaceuticals, Inc.
mi
from
Waltham, MA
A Phase IV Trial of Repeated Doses of Ferumoxytol Compared to Iron Sucrose for the Treatment of Iron Deficiency Anemia in Patients With Chronic Kidney Disease on Hemodialysis
Ferumoxytol for Anemia of CKD Trial (FACT): A Phase IV, Open-Label, Multicenter Trial, With MRI Substudy, of Repeated Doses of Ferumoxytol Compared With Iron Sucrose for the Treatment of Iron Deficiency Anemia (IDA) in Chronic Kidney Disease (CKD) Patients on Hemodialysis
Status: Enrolling
Updated: 11/14/2017
AMAG Pharmaceuticals, Inc.
mi
from
Waltham, MA
Click here to add this to my saved trials
Gut Microbiome and p-Inulin in CKD - TarGut CKD Study
Gut Microbiome and p-Inulin in CKD TarGut CKD Study
Status: Enrolling
Updated:  11/15/2017
George Washington University Medical Faculty Associates
mi
from
Washington,
Gut Microbiome and p-Inulin in CKD - TarGut CKD Study
Gut Microbiome and p-Inulin in CKD TarGut CKD Study
Status: Enrolling
Updated: 11/15/2017
George Washington University Medical Faculty Associates
mi
from
Washington,
Click here to add this to my saved trials
Intelligent Control Approach to Anemia Management
Intelligent Control Approach to Anemia Management (AIM 4)
Status: Enrolling
Updated:  11/15/2017
University of Louisville - Kidney Disease Program
mi
from
Louisville, KY
Intelligent Control Approach to Anemia Management
Intelligent Control Approach to Anemia Management (AIM 4)
Status: Enrolling
Updated: 11/15/2017
University of Louisville - Kidney Disease Program
mi
from
Louisville, KY
Click here to add this to my saved trials
A Study in Participants With Diabetic Kidney Disease
A Randomized, Double-Masked, Placebo-Controlled, Multicenter, Phase 2 Study to Evaluate the Safety and Renal Efficacy of LY2382770 in Patients With Diabetic Kidney Disease Due to Type 1 or Type 2 Diabetes
Status: Enrolling
Updated:  11/17/2017
Clinical Research Facility
mi
from
Kansas City, MO
A Study in Participants With Diabetic Kidney Disease
A Randomized, Double-Masked, Placebo-Controlled, Multicenter, Phase 2 Study to Evaluate the Safety and Renal Efficacy of LY2382770 in Patients With Diabetic Kidney Disease Due to Type 1 or Type 2 Diabetes
Status: Enrolling
Updated: 11/17/2017
Clinical Research Facility
mi
from
Kansas City, MO
Click here to add this to my saved trials
A Study in Participants With Diabetic Kidney Disease
A Randomized, Double-Masked, Placebo-Controlled, Multicenter, Phase 2 Study to Evaluate the Safety and Renal Efficacy of LY2382770 in Patients With Diabetic Kidney Disease Due to Type 1 or Type 2 Diabetes
Status: Enrolling
Updated:  11/17/2017
Clinical Research Facility
mi
from
Phoenix, AZ
A Study in Participants With Diabetic Kidney Disease
A Randomized, Double-Masked, Placebo-Controlled, Multicenter, Phase 2 Study to Evaluate the Safety and Renal Efficacy of LY2382770 in Patients With Diabetic Kidney Disease Due to Type 1 or Type 2 Diabetes
Status: Enrolling
Updated: 11/17/2017
Clinical Research Facility
mi
from
Phoenix, AZ
Click here to add this to my saved trials
A Study in Participants With Diabetic Kidney Disease
A Randomized, Double-Masked, Placebo-Controlled, Multicenter, Phase 2 Study to Evaluate the Safety and Renal Efficacy of LY2382770 in Patients With Diabetic Kidney Disease Due to Type 1 or Type 2 Diabetes
Status: Enrolling
Updated:  11/17/2017
Clinical Research Facility
mi
from
Inglewood, CA
A Study in Participants With Diabetic Kidney Disease
A Randomized, Double-Masked, Placebo-Controlled, Multicenter, Phase 2 Study to Evaluate the Safety and Renal Efficacy of LY2382770 in Patients With Diabetic Kidney Disease Due to Type 1 or Type 2 Diabetes
Status: Enrolling
Updated: 11/17/2017
Clinical Research Facility
mi
from
Inglewood, CA
Click here to add this to my saved trials
A Study in Participants With Diabetic Kidney Disease
A Randomized, Double-Masked, Placebo-Controlled, Multicenter, Phase 2 Study to Evaluate the Safety and Renal Efficacy of LY2382770 in Patients With Diabetic Kidney Disease Due to Type 1 or Type 2 Diabetes
Status: Enrolling
Updated:  11/17/2017
Clinical Research Facility
mi
from
Los Angeles, CA
A Study in Participants With Diabetic Kidney Disease
A Randomized, Double-Masked, Placebo-Controlled, Multicenter, Phase 2 Study to Evaluate the Safety and Renal Efficacy of LY2382770 in Patients With Diabetic Kidney Disease Due to Type 1 or Type 2 Diabetes
Status: Enrolling
Updated: 11/17/2017
Clinical Research Facility
mi
from
Los Angeles, CA
Click here to add this to my saved trials
A Study in Participants With Diabetic Kidney Disease
A Randomized, Double-Masked, Placebo-Controlled, Multicenter, Phase 2 Study to Evaluate the Safety and Renal Efficacy of LY2382770 in Patients With Diabetic Kidney Disease Due to Type 1 or Type 2 Diabetes
Status: Enrolling
Updated:  11/17/2017
Clinical Research Facility
mi
from
Northridge, CA
A Study in Participants With Diabetic Kidney Disease
A Randomized, Double-Masked, Placebo-Controlled, Multicenter, Phase 2 Study to Evaluate the Safety and Renal Efficacy of LY2382770 in Patients With Diabetic Kidney Disease Due to Type 1 or Type 2 Diabetes
Status: Enrolling
Updated: 11/17/2017
Clinical Research Facility
mi
from
Northridge, CA
Click here to add this to my saved trials
A Study in Participants With Diabetic Kidney Disease
A Randomized, Double-Masked, Placebo-Controlled, Multicenter, Phase 2 Study to Evaluate the Safety and Renal Efficacy of LY2382770 in Patients With Diabetic Kidney Disease Due to Type 1 or Type 2 Diabetes
Status: Enrolling
Updated:  11/17/2017
Clinical Research Facility
mi
from
Denver, CO
A Study in Participants With Diabetic Kidney Disease
A Randomized, Double-Masked, Placebo-Controlled, Multicenter, Phase 2 Study to Evaluate the Safety and Renal Efficacy of LY2382770 in Patients With Diabetic Kidney Disease Due to Type 1 or Type 2 Diabetes
Status: Enrolling
Updated: 11/17/2017
Clinical Research Facility
mi
from
Denver, CO
Click here to add this to my saved trials
A Study in Participants With Diabetic Kidney Disease
A Randomized, Double-Masked, Placebo-Controlled, Multicenter, Phase 2 Study to Evaluate the Safety and Renal Efficacy of LY2382770 in Patients With Diabetic Kidney Disease Due to Type 1 or Type 2 Diabetes
Status: Enrolling
Updated:  11/17/2017
Clinical Research Facility
mi
from
Port Charlotte, FL
A Study in Participants With Diabetic Kidney Disease
A Randomized, Double-Masked, Placebo-Controlled, Multicenter, Phase 2 Study to Evaluate the Safety and Renal Efficacy of LY2382770 in Patients With Diabetic Kidney Disease Due to Type 1 or Type 2 Diabetes
Status: Enrolling
Updated: 11/17/2017
Clinical Research Facility
mi
from
Port Charlotte, FL
Click here to add this to my saved trials
A Study in Participants With Diabetic Kidney Disease
A Randomized, Double-Masked, Placebo-Controlled, Multicenter, Phase 2 Study to Evaluate the Safety and Renal Efficacy of LY2382770 in Patients With Diabetic Kidney Disease Due to Type 1 or Type 2 Diabetes
Status: Enrolling
Updated:  11/17/2017
Clinical Research Facility
mi
from
Tampa, FL
A Study in Participants With Diabetic Kidney Disease
A Randomized, Double-Masked, Placebo-Controlled, Multicenter, Phase 2 Study to Evaluate the Safety and Renal Efficacy of LY2382770 in Patients With Diabetic Kidney Disease Due to Type 1 or Type 2 Diabetes
Status: Enrolling
Updated: 11/17/2017
Clinical Research Facility
mi
from
Tampa, FL
Click here to add this to my saved trials
A Study in Participants With Diabetic Kidney Disease
A Randomized, Double-Masked, Placebo-Controlled, Multicenter, Phase 2 Study to Evaluate the Safety and Renal Efficacy of LY2382770 in Patients With Diabetic Kidney Disease Due to Type 1 or Type 2 Diabetes
Status: Enrolling
Updated:  11/17/2017
Clinical Research Facility
mi
from
Atlanta, GA
A Study in Participants With Diabetic Kidney Disease
A Randomized, Double-Masked, Placebo-Controlled, Multicenter, Phase 2 Study to Evaluate the Safety and Renal Efficacy of LY2382770 in Patients With Diabetic Kidney Disease Due to Type 1 or Type 2 Diabetes
Status: Enrolling
Updated: 11/17/2017
Clinical Research Facility
mi
from
Atlanta, GA
Click here to add this to my saved trials
A Study in Participants With Diabetic Kidney Disease
A Randomized, Double-Masked, Placebo-Controlled, Multicenter, Phase 2 Study to Evaluate the Safety and Renal Efficacy of LY2382770 in Patients With Diabetic Kidney Disease Due to Type 1 or Type 2 Diabetes
Status: Enrolling
Updated:  11/17/2017
Clinical Research Facility
mi
from
Idaho Falls, ID
A Study in Participants With Diabetic Kidney Disease
A Randomized, Double-Masked, Placebo-Controlled, Multicenter, Phase 2 Study to Evaluate the Safety and Renal Efficacy of LY2382770 in Patients With Diabetic Kidney Disease Due to Type 1 or Type 2 Diabetes
Status: Enrolling
Updated: 11/17/2017
Clinical Research Facility
mi
from
Idaho Falls, ID
Click here to add this to my saved trials
A Study in Participants With Diabetic Kidney Disease
A Randomized, Double-Masked, Placebo-Controlled, Multicenter, Phase 2 Study to Evaluate the Safety and Renal Efficacy of LY2382770 in Patients With Diabetic Kidney Disease Due to Type 1 or Type 2 Diabetes
Status: Enrolling
Updated:  11/17/2017
Clinical Research Facility
mi
from
Wichita, KA
A Study in Participants With Diabetic Kidney Disease
A Randomized, Double-Masked, Placebo-Controlled, Multicenter, Phase 2 Study to Evaluate the Safety and Renal Efficacy of LY2382770 in Patients With Diabetic Kidney Disease Due to Type 1 or Type 2 Diabetes
Status: Enrolling
Updated: 11/17/2017
Clinical Research Facility
mi
from
Wichita, KA
Click here to add this to my saved trials
A Study in Participants With Diabetic Kidney Disease
A Randomized, Double-Masked, Placebo-Controlled, Multicenter, Phase 2 Study to Evaluate the Safety and Renal Efficacy of LY2382770 in Patients With Diabetic Kidney Disease Due to Type 1 or Type 2 Diabetes
Status: Enrolling
Updated:  11/17/2017
Clinical Research Facility
mi
from
Kenner, LA
A Study in Participants With Diabetic Kidney Disease
A Randomized, Double-Masked, Placebo-Controlled, Multicenter, Phase 2 Study to Evaluate the Safety and Renal Efficacy of LY2382770 in Patients With Diabetic Kidney Disease Due to Type 1 or Type 2 Diabetes
Status: Enrolling
Updated: 11/17/2017
Clinical Research Facility
mi
from
Kenner, LA
Click here to add this to my saved trials
A Study in Participants With Diabetic Kidney Disease
A Randomized, Double-Masked, Placebo-Controlled, Multicenter, Phase 2 Study to Evaluate the Safety and Renal Efficacy of LY2382770 in Patients With Diabetic Kidney Disease Due to Type 1 or Type 2 Diabetes
Status: Enrolling
Updated:  11/17/2017
Clinical Research Facility
mi
from
Rockville, MD
A Study in Participants With Diabetic Kidney Disease
A Randomized, Double-Masked, Placebo-Controlled, Multicenter, Phase 2 Study to Evaluate the Safety and Renal Efficacy of LY2382770 in Patients With Diabetic Kidney Disease Due to Type 1 or Type 2 Diabetes
Status: Enrolling
Updated: 11/17/2017
Clinical Research Facility
mi
from
Rockville, MD
Click here to add this to my saved trials
A Study in Participants With Diabetic Kidney Disease
A Randomized, Double-Masked, Placebo-Controlled, Multicenter, Phase 2 Study to Evaluate the Safety and Renal Efficacy of LY2382770 in Patients With Diabetic Kidney Disease Due to Type 1 or Type 2 Diabetes
Status: Enrolling
Updated:  11/17/2017
Clinical Research Facility
mi
from
Omaha, NE
A Study in Participants With Diabetic Kidney Disease
A Randomized, Double-Masked, Placebo-Controlled, Multicenter, Phase 2 Study to Evaluate the Safety and Renal Efficacy of LY2382770 in Patients With Diabetic Kidney Disease Due to Type 1 or Type 2 Diabetes
Status: Enrolling
Updated: 11/17/2017
Clinical Research Facility
mi
from
Omaha, NE
Click here to add this to my saved trials
A Study in Participants With Diabetic Kidney Disease
A Randomized, Double-Masked, Placebo-Controlled, Multicenter, Phase 2 Study to Evaluate the Safety and Renal Efficacy of LY2382770 in Patients With Diabetic Kidney Disease Due to Type 1 or Type 2 Diabetes
Status: Enrolling
Updated:  11/17/2017
Clinical Research Facility
mi
from
Chapel Hill, NC
A Study in Participants With Diabetic Kidney Disease
A Randomized, Double-Masked, Placebo-Controlled, Multicenter, Phase 2 Study to Evaluate the Safety and Renal Efficacy of LY2382770 in Patients With Diabetic Kidney Disease Due to Type 1 or Type 2 Diabetes
Status: Enrolling
Updated: 11/17/2017
Clinical Research Facility
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
A Study in Participants With Diabetic Kidney Disease
A Randomized, Double-Masked, Placebo-Controlled, Multicenter, Phase 2 Study to Evaluate the Safety and Renal Efficacy of LY2382770 in Patients With Diabetic Kidney Disease Due to Type 1 or Type 2 Diabetes
Status: Enrolling
Updated:  11/17/2017
Clinical Research Facility
mi
from
Charlotte, NC
A Study in Participants With Diabetic Kidney Disease
A Randomized, Double-Masked, Placebo-Controlled, Multicenter, Phase 2 Study to Evaluate the Safety and Renal Efficacy of LY2382770 in Patients With Diabetic Kidney Disease Due to Type 1 or Type 2 Diabetes
Status: Enrolling
Updated: 11/17/2017
Clinical Research Facility
mi
from
Charlotte, NC
Click here to add this to my saved trials
A Study in Participants With Diabetic Kidney Disease
A Randomized, Double-Masked, Placebo-Controlled, Multicenter, Phase 2 Study to Evaluate the Safety and Renal Efficacy of LY2382770 in Patients With Diabetic Kidney Disease Due to Type 1 or Type 2 Diabetes
Status: Enrolling
Updated:  11/17/2017
Clinical Research Facility
mi
from
Durham, NC
A Study in Participants With Diabetic Kidney Disease
A Randomized, Double-Masked, Placebo-Controlled, Multicenter, Phase 2 Study to Evaluate the Safety and Renal Efficacy of LY2382770 in Patients With Diabetic Kidney Disease Due to Type 1 or Type 2 Diabetes
Status: Enrolling
Updated: 11/17/2017
Clinical Research Facility
mi
from
Durham, NC
Click here to add this to my saved trials